טוען...
The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
BACKGROUND: Treatment for local and locoregional recurrence or second head-and-neck (H&N) cancers after previous radiotherapy is challenging, and re-irradiation carries a significantly increased risk for radiotherapy-related normal tissue toxicities and treatment failure due to a radioresistant...
שמור ב:
| הוצא לאור ב: | Radiat Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7164259/ https://ncbi.nlm.nih.gov/pubmed/32299456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-020-01531-5 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|